Looking for "Implicit Bias Training for Michigan Healthcare Professionals"? CLICK HERE

Do No Harm
Donate

Main Menu

    • About Us
    • The Team
    • Frequently Asked Questions
    • What Others Say
    • Voices of Do No Harm
    • Newsroom
    • Issue Awareness
    • Federal Policy
    • State Policy
    • Litigation
    • Research
    • Resources
    • Centers
    • Submit a Tip
    • Become a Member
    • Careers
    • Make a Donation
    • Share Your Concern
    • Attend an Event
    • Listen to Our Podcast
  • Donate
  • Media Inquiries
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
Search

Commentary

Do No Harm Submits FTC Comment Debunking Myths of Child Transgender Industry

  • By Do No Harm Staff
  • September 29, 2025

Share:

  • Twitter
  • Facebook
  • LinkedIn
  • WhatsApp
  • Buffer

FTC

This month, Do No Harm submitted a comment to the Federal Trade Commission (FTC) debunking several myths promoted by the child transgender industry.

The FTC had requested comments on how the child transgender industry’s practices harmed Americans, such as through a medical professional making false claims or failing to disclose the risks of sex change interventions. 

The request followed a workshop hosted by the FTC in which multiple experts, including Do No Harm fellows, highlighted the misleading and deceptive practices employed by the child transgender industry.

Do No Harm’s comment takes on several of the most pervasive and pernicious myths employed by gender ideologues.

First, the comment explains how the myth that sex change interventions reduce the risk of suicide is completely unsupported by evidence.

“This emotional blackmail is completely unsupported by the evidence,” the comment states. “As admitted by a researcher for WPATH (one of the organizations that signed on to the previously cited amicus brief): ‘There is insufficient evidence to draw a conclusion about the effect of hormone therapy on death by suicide among transgender people.’”

Next, the comment debunks the notion that child sex change interventions are safe and effective, pointing to ample evidence, such as the Cass Review and other comprehensive reports, finding the opposite.

“All systematic reviews performed on this topic have concluded that the evidence underlying medical interventions for gender dysphoria in minors is weak; zero have come out the other way,” the comment notes.

The comment then points out that claims of puberty blockers being “reversible” is likewise a myth as “the effect of pubertal suppression on neurodevelopment is wholly unknown.” Finally, the comment debunks the claim that the rate of “regret” for minors who have undergone pediatric medical transition is low, pointing both to the paucity of evidence on the topic as well as studies that have found the rate to be significant.

Read the full comment here.

Promoted Links

Group of doctors

Become a Member

Help us protect patients, physicians, and healthcare itself from radical, divisive ideology.

JOIN US

Single doctors

Share Your Concern

Have you seen divisive ideology or discrimination at your healthcare employer, medical school, or medical provider? Let us know – anonymously.

Share Anonymously

Stay Informed

Get up to speed with the threats facing healthcare – and how we’re protecting patients and physicians.

Folder

"*" indicates required fields

Do No Harm
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
Search
  • Contact
  • Search
  • Our Story

    • About Us
    • The Team
    • Frequently Asked Questions
    • What Others Say
    • Voices of Do No Harm
  • Our Work

    • Newsroom
    • Issue Awareness
      • Identity Politics (DEI)
      • Gender Ideology
    • Federal Policy
    • State Policy
    • Litigation
    • Research
    • Resources
    • Centers
  • Get Involved

    • Submit a Tip
    • Become a Member
    • Careers
    • Make a Donation
    • Share Your Concern
    • Attend an Event
    • Listen to Our Podcast

© Do No Harm 2025 | Privacy Policy | Disclaimer